Skip to main content
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. logo

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 605016 ISIN · CNE1000052N4 LEI · 836800JRHZN5DN83BW33 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2026-06-04 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 605016

About Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.

https://www.chinabailong.com/

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. is a biotechnology enterprise specializing in the research, development, and large-scale production of functional food ingredients. The company focuses on prebiotics, dietary fibers, and healthy sugar substitutes. Its core product portfolio includes isomalto-oligosaccharides (IMO), fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), polydextrose, resistant dextrin, and allulose. These ingredients are widely utilized in the food, beverage, healthcare, and pharmaceutical sectors to enhance nutritional profiles and support digestive health. Leveraging advanced fermentation and extraction technologies, the company maintains a significant global market presence, providing high-purity solutions that meet international quality standards for clean-label and low-calorie applications.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 30% confidence The document is an announcement of the controlling shareholder’s release of pledged shares (解除质押). It does not involve an actual share issue, repurchase, dividend, management change, or a formal financial report. It is not a purchase/sale of the company’s own shares, nor a director insider trade in the sense of buying/selling shares, and no threshold of shareholding is altered. Therefore it falls under miscellaneous regulatory announcements. Classification: Regulatory Filings (RNS).
2026-06-04 Chinese
2025年年度权益分派实施公告
Notice of Dividend Amount Classification · 92% confidence The document is an announcement by a listed company detailing its annual profit distribution scheme for the 2025 fiscal year – specifying the cash dividend per share, record date, ex-dividend date, payment date, total dividend amount, and related tax treatment. This fits precisely with a Notice of Dividend Amount (DIV).
2026-05-26 Chinese
关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 75% confidence The document is a corporate announcement (“公告”) in Chinese regarding the company’s participation in a 2026 online investor reception day organized by regulatory bodies. It provides logistical details (date, time, platform) and topics for discussion but does not present financial results, governance rules, voting outcomes, or attach any formal report or presentation. This type of notice does not match specific categories like earnings release, investor presentation (which would include actual slides or detailed content), or a proxy statement, but rather is a general regulatory announcement to investors. Therefore, it falls under the fallback category “Regulatory Filings (RNS).”
2026-05-13 Chinese
山东百龙创园生物科技股份有限公司职工代表董事选任制度
Governance Information Classification · 95% confidence The document is titled '职工代表董事选任制度' which translates to 'Employee Representative Director Election System'. It details the governance structure, nomination, election, qualifications, rights, duties, and management of employee representative directors within the company. The content focuses on internal governance rules and procedures rather than financial performance, audit results, or shareholder meeting materials. There is no indication of financial data, regulatory filings, or announcements related to capital, dividends, or legal proceedings. The document is a governance policy document outlining internal rules and board structure related to employee representative directors. Therefore, it fits best under Governance Information (CGR). The document length is 3311 characters, which is consistent with a detailed governance policy rather than a brief announcement or report publication notice.
2026-04-07 Chinese
2025年度审计报告
Audit Report / Information Classification · 95% confidence The document is titled “二〇二五年度 审计报告” and is issued by a registered accounting firm with audit opinion, basis, key audit matters, and includes audited financial statements (balance sheet, income statement, cash flow, equity changes, and notes). It is a standalone audit report containing actual audit procedures and audited financial data, matching the definition of an Audit Report / Information. Therefore, the correct classification is AR. FY 2025
2026-04-07 Chinese
山东百龙创园生物科技股份有限公司董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 100% confidence The document is titled '董事、高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management'. It details the principles, structure, management, and payment of remuneration for directors and senior management of the company. It includes sections on remuneration composition, standards, management institutions, responsibility accountability, and related policies. There is no financial data or report of financial results, nor is it an announcement or presentation. The content is focused on remuneration policies and management, which aligns with the definition of Remuneration Information (DEF 14A). The document length is 3776 characters, which is sufficient for a detailed policy document rather than a brief announcement. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2026-04-07 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.